|
Bulk drugs imports decline 22%, exports grow over 11% in H1FY26
|
|
Gireesh Babu, New Delhi
November 02 , 2026
|
|
|
Import of bulk drugs and intermediates to India has reported a decline of 22.22% in the first half of the fiscal year 2026-27, at $$1.75 billion as compared to $2.25 billion during the same period of previous fiscal year.
Exports of bulk drugs, during the first six months ended September 30, 2026, grew 11.74%, at $2.76 billion as compared to $2.47 billion exports during the same period of last year, according to data from the ministry of commerce and industry.
In rupee terms, imports declined 13.79% in the first six months, at Rs. 16,731.7 crore, as compared to Rs. 19,408.8 crore during the same period a year ago. Quantity of imports declined around 22% at 1,96,442.01 MT during April to September, 2026, as against 2,51,978.06 MT during the comparable period last year.
Exports, in rupee terms, grew 23.39% to Rs. 26,313.6 crore against Rs. 21,325.6 crore during the first half of the fiscal year. Quantity of exports grew 5.58% to 2,55,475.2 MT in April to September, this year, as compared to 2,41,980.2 MT during the same period last year.
During the second quarter ended September 30, 2026, imports were down by 12.07%, at $1.02 billion as against $1.16 billion during the same quarter last year. In rupee terms, this was a decline of 3.74% to Rs. 9,745.84 crore, compared to Rs. 10,124.1 crore last year. Quantity of imports during the quarter declined 13.86% to 1,07,587.77 MT as against 1,24,900.9 MT in the same quarter of last year.
Exports during the three months grew 10.24% to $1.4 billion, as compared to $1.27 billion. In rupee terms, this was a 20.77% growth at Rs. 13,374.4 crore as compared to Rs. 11,074 crore during the comparable quarters. Quantity grew 5.90% to 1,28,963 MT as against 1,21,779.51 MT, says official data.
Imports during the month of September, 2026 declined 13.06% to $308.11 million, from $354.4 million on a Year-over-Year basis. In rupee terms, imports declined 6.03% to Rs. 2,941.37 crore compared to Rs. 3,130.16 crore imports a year ago. Quantity of imports also reduced by 20.41% to 31,685.16 MT from 39,310.08 MT during the month of September.
Meanwhile, exports of bulk drugs and intermediates during the month of September grew 14.62% to $509.25 million compared to $444.30 million in the same month of last year. In rupee terms, this was a 23.89% growth at Rs. 4,861.53 crore, as compared to Rs. 3,924.2 crore registered in September, 2025. Quantity of exports grew 22.36% to 45,244.74 MT in September, this year, as compared to 36,975.34 MT exported in the same month, a year ago.
The Central government has been emphasising on reducing the imports of essential pharmaceutical raw materials such as bulk drugs, drug intermediates and key starting materials, among others, and has initiated various incentive schemes to support domestic production of these materials.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|